Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target

Baraka Simon Mayamba, Abdallah Iddy Chaurembo, Francis Chanda, Xu Zheng, Yun-tao Liang, Wen-hui Deng, Yue Liu, Zi-feng Huang, Yong-fang Lin, Na Xing, Peter P. Liu, Han-bin Lin
Acta Pharmacologica Sinica · Springer Nature · 2026-11-10 · DOI: 10.1038/s41401-026-01954-y

Аннотация

Acta Pharmacologica Sinica, Published online: 10 November 2026; doi:10.1038/s41401-026-01954-y Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target

Читать у издателя →

Похожие статьи